VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Kelun-Biotech (06990.HK) Surges as Merck ADC Combo Therapy Defeats Keytruda Monotherapy
Kelun-Biotech (06990.HK) Surges as Merck ADC Combo Therapy Defeats Keytruda Monotherapy
May 22, 2026 09:32 CST Updated 10:08
Share:
